This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.
Latest papers
Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer.
PloS one · 2026
Combinatorial approaches for cancer immunotherapy.
Cancer immunology, immunotherapy : CII · 2026 · senior author
Response of non-small cell lung cancer harboring different epidermal growth factor receptor mutations to ablative radiotherapy.
Translational lung cancer research · 2025
Latest funding
- $60,000
Targeting immunosuppressive chemokines for enhanced response to radiotherapy in squamous cell cancers
CIHR · 2021 · Nominated PI
- $120,000
Development of an immune imaging method to accurately determine the immune status of tumors
NSERC · 2020 · Principal investigator
- $600,000
Canada Research Chairs - Tier 2
CIHR · 2020 · Nominated PI
7 publications.
Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer.
Paquette B, Therriault H, Gauthier I, Provencher S, Bourque JM, Naasri S, Oweida A, Geha S, Labrecque P, Parent JL
Combinatorial approaches for cancer immunotherapy.
Spada S, Oweida A
Response of non-small cell lung cancer harboring different epidermal growth factor receptor mutations to ablative radiotherapy.
Al Rabea A, Gerard IJ, Daniel P, Camilleri-Broët S, Oweida A, Sabri S, Abdulkarim B
Combination of radiotherapy and immunotherapy in duality with the protumoral action of radiation.
Paquette B, Oweida A
Reconciling two opposing effects of radiation therapy: stimulation of cancer cell invasion and activation of anti-cancer immunity.
Oweida A, Paquette B
Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma.
Knitz MW, Darragh LB, Bickett TE, Bhatia S, Bukkapatnam S, Gadwa J, Piper M, Corbo S, Nguyen D, Van Court B, Oweida A, Karam SD
Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response.
Korpela SP, Hinz TK, Oweida A, Kim J, Calhoun J, Ferris R, Nemenoff RA, Karam SD, Clambey ET, Heasley LE
Targeting immunosuppressive chemokines for enhanced response to radiotherapy in squamous cell cancers
Principal investigators: Oweida, Ayman
Keywords: Immunotherapy Translational Research
Development of an immune imaging method to accurately determine the immune status of tumors
Principal investigators: Oweida, Ayman
Canada Research Chairs - Tier 2
Principal investigators: Oweida, Ayman
Keywords: Crc
Development of an immune imaging method to accurately determine the immune status of tumors
Principal investigators: Oweida, Ayman
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Médecine
- Other
Co-authors at Université de Sherbrooke, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.